Sorry, you need to enable JavaScript to visit this website.

Lyrica U.S. Clinical Trials Currently Recruiting Patients

MAY 2018

A listing of U.S. Lyrica clinical trials under investigation that are currently recruiting patients or pending recruitment can be found below. For information on these trials, including information on potential patient participation in these trials, please click on the links provided.

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures

NEED ADDITIONAL INFORMATION?

Call or email to reach a Pfizer Clinical Trial Contact Center representative.

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

For a listing of all ongoing clinical trials for Lyrica or to enroll a patient(s) in additional ongoing Lyrica clinical trials, please go to www.clinicaltrials.gov and search for ‘Lyrica’ or ‘pregabalin’.